Gateway to Think Tanks
来源类型 | Report |
规范类型 | 报告 |
DOI | https://doi.org/10.7249/RRA328-1 |
来源ID | RR-A328-1 |
Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships | |
Andrew W. Mulcahy; Vishnupriya Kareddy | |
发表日期 | 2021-10-27 |
出版年 | 2021 |
页码 | 49 |
语种 | 英语 |
结论 |
|
摘要 | The authors describe the stakeholders involved in prescription drug supply chains and the flows of products, payments, and information between stakeholders. Many stakeholders and steps are involved in the life cycle of a prescription drug as it moves from chemical synthesis and formulation through dispensing or administration to patients. The specific steps involved in prescription drug supply chains often differ depending on the type of drug, the channel of distribution, and the patient's source of prescription drug coverage. Although the authors present a typical supply chain for retail pharmacy drugs, they also highlight the important supply chain distinctions for specific distribution channels and for specific types of drugs. Disparate sources exist describing each component of the supply chain, but, to the authors' knowledge, this report is the first to compile them to facilitate understanding of their interdependence and complexity. ,The typical stakeholders, relationships, and financial incentives in prescription drug supply chains vary depending on the characteristics of a drug and how it reaches patients. Even within a specific type of drug and a particular distribution channel, differences in business practices complicate a universal description of drug supply chains. There are four common core components of drug supply chains: manufacturing, distribution, coverage and payment, and prescribing and demand. ,Although prescription drugs are generally available to dispense when prescribed in the United States, there are important exceptions that warrant further investigation. The ability of policymakers to identify, assess, and respond to shortages and disruptions in supply chains is hampered by incomplete data. |
目录 |
|
主题 | Health Care Costs ; Health Care Payment Approaches ; Medicaid ; Pharmaceutical Drugs ; United States |
URL | https://www.rand.org/pubs/research_reports/RRA328-1.html |
来源智库 | RAND Corporation (United States) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/524607 |
推荐引用方式 GB/T 7714 | Andrew W. Mulcahy,Vishnupriya Kareddy. Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships. 2021. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
RAND_RRA328-1.pdf(515KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
x1635338191976.jpg.p(1KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。